Fig. 4.
Mean change from baseline in SGRQ domain scores in the ITT population. Treatment differences (95% CIs) shown. *P < 0.05; **P < 0.01; ***P < 0.001. BUD/FOR budesonide/formoterol, CI confidence interval, FF/UMEC/VI fluticasone furoate/umeclidinium/vilanterol, ITT intent-to-treat, LS least squares, SGRQ St George’s Respiratory Questionnaire